These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 27117668)
1. Label-free cell phenotypic profiling and pathway deconvolution of neurotensin receptor-1. Hou T; Shi L; Wang J; Wei L; Qu L; Zhang X; Liang X Pharmacol Res; 2016 Jun; 108():39-45. PubMed ID: 27117668 [TBL] [Abstract][Full Text] [Related]
2. Label-free cell phenotypic assessment of the biased agonism and efficacy of agonists at the endogenous muscarinic M3 receptors. Deng H; Sun H; Fang Y J Pharmacol Toxicol Methods; 2013; 68(3):323-33. PubMed ID: 23933114 [TBL] [Abstract][Full Text] [Related]
3. The signaling signature of the neurotensin type 1 receptor with endogenous ligands. Besserer-Offroy É; Brouillette RL; Lavenus S; Froehlich U; Brumwell A; Murza A; Longpré JM; Marsault É; Grandbois M; Sarret P; Leduc R Eur J Pharmacol; 2017 Jun; 805():1-13. PubMed ID: 28341345 [TBL] [Abstract][Full Text] [Related]
4. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes. Kitabgi P Curr Opin Drug Discov Devel; 2002 Sep; 5(5):764-76. PubMed ID: 12630297 [TBL] [Abstract][Full Text] [Related]
5. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals. Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421 [TBL] [Abstract][Full Text] [Related]
6. Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis. Bossard C; Souazé F; Jarry A; Bezieau S; Mosnier JF; Forgez P; Laboisse CL Peptides; 2007 Oct; 28(10):2030-5. PubMed ID: 17870207 [TBL] [Abstract][Full Text] [Related]
7. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations. Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646 [TBL] [Abstract][Full Text] [Related]
8. Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation. Souazé F; Forgez P Peptides; 2006 Oct; 27(10):2493-501. PubMed ID: 16889873 [TBL] [Abstract][Full Text] [Related]
9. Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders. Tanganelli S; Antonelli T; Tomasini MC; Beggiato S; Fuxe K; Ferraro L Curr Med Chem; 2012; 19(3):304-16. PubMed ID: 22335510 [TBL] [Abstract][Full Text] [Related]
11. Cell-type-specific pathways of neurotensin endocytosis. Savdie C; Ferguson SS; Vincent J; Beaudet A; Stroh T Cell Tissue Res; 2006 Apr; 324(1):69-85. PubMed ID: 16374621 [TBL] [Abstract][Full Text] [Related]
12. Neurotensin NTS Steele FF; Whitehouse SC; Aday JS; Prus AJ Brain Res; 2017 Mar; 1658():31-35. PubMed ID: 28089664 [TBL] [Abstract][Full Text] [Related]
13. Optimization and Bumbak F; Keen AC; Gunn NJ; Gooley PR; Bathgate RAD; Scott DJ Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1372-1383. PubMed ID: 29596791 [TBL] [Abstract][Full Text] [Related]
14. Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress. Carraway RE; Hassan S Regul Pept; 2007 Jun; 141(1-3):140-53. PubMed ID: 17289170 [TBL] [Abstract][Full Text] [Related]
15. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands. Prus AJ; Schuck CJ; Rusch KR; Carey LM Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440 [TBL] [Abstract][Full Text] [Related]
16. Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease. Kühl T; Georgieva MG; Hübner H; Lazarova M; Vogel M; Haas B; Peeva MI; Balacheva AA; Bogdanov IP; Milella L; Ponticelli M; Garev T; Faraone I; Detcheva R; Minchev B; Petkova-Kirova P; Tancheva L; Kalfin R; Atanasov AG; Antonov L; Pajpanova TI; Kirilov K; Gastreich M; Gmeiner P; Imhof D; Tzvetkov NT Eur J Med Chem; 2023 Jun; 254():115386. PubMed ID: 37094450 [TBL] [Abstract][Full Text] [Related]
17. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons. Jomphe C; Lemelin PL; Okano H; Kobayashi K; Trudeau LE Eur J Neurosci; 2006 Nov; 24(10):2789-800. PubMed ID: 17116165 [TBL] [Abstract][Full Text] [Related]
18. Modulation of the interaction between neurotensin receptor NTS1 and Gq protein by lipid. Inagaki S; Ghirlando R; White JF; Gvozdenovic-Jeremic J; Northup JK; Grisshammer R J Mol Biol; 2012 Mar; 417(1-2):95-111. PubMed ID: 22306739 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies. Ruzza C; Ferrari F; Guerrini R; Marzola E; Preti D; Reinscheid RK; Calo G Pharmacol Res Perspect; 2018 Dec; 6(6):e00445. PubMed ID: 30534379 [TBL] [Abstract][Full Text] [Related]